CClinicalTrials.gg
RecruitingNCT06138340Updated Feb 14, 2025

The Effects of Anesthetics on Brain Network Connectivity in Patients With Supratentorial Glioma

An observational study in Brain Network Connectivity, Postoperative Delirium and Dexmedetomidine, sponsored by Beijing Tiantan Hospital. Recruiting at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-02-14.

Sponsored by Beijing Tiantan Hospital · Observational

From the registry’s dates

  • Primary completion was expected by Nov 2025, 10 months ago, but the record still lists the study as recruiting.
  • Started Aug 2023; still recruiting 3 years 1 month later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
120
Ages
18 Years and older
Sex
All
01

Study summary

Perioperative anesthesia can affect postoperative cognitive function. In our previous study, intraoperative dexmedetomidine (Dex) infusion reduced the incidence of delirium within the first 5 days after brain tumor. However, the mechanism is still unclear. With the development of neuroimaging, multimodal neuroimaging technology provide a new method to explore the underlying mechanism. Therefore, the purpose of this study is to analyze the alterations of brain network under sedation and anesthesia by different anesthetics in patients with supratentorial glioma and their association with cognition.

02

Conditions studied

  • Brain Network Connectivity
  • Postoperative Delirium
  • Dexmedetomidine
  • Propofol

Browse trials for

03

In context

Emergence Delirium

763 studies on the registry are indexed under Emergence Delirium; 241 are open to participants now.

This study's planned enrollment of 120 is below the median of 164 across 280 observational studies indexed under Emergence Delirium.

Browse Emergence Delirium studies →

Lead sponsor

Beijing Tiantan Hospital is the lead sponsor of 465 studies on the registry; 282 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

The population will be selected from patients who schedule to receive elective surgery in Beijing Tiantan Hospital.

Inclusion criteria

  • Diagnosed as unilateral supratentorial glioma by MRI
  • Selective operation
  • Age over 18 years old
  • ASA I-II
  • Right handedness

Exclusion criteria

Exclusion Criteria:

  • History of cerebrovascular disease, brain trauma, chemotherapy and radiotherapy, or psychotropic drugs
  • History of intracranial surgery
  • Drug and/or alcohol abuse
  • History of dementia or mental illness
  • Pregnant or lactating women
  • Contraindications for MRI
  • Severe bradycardia (heart rate less than 40 beats per minute), sick sinus syndrome or second-to-third degree atrioventricular block
  • Severe hepatic or renal dysfunction
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
120 participants (estimated)
Patient registry
No

Groups and cohorts

  • Dex group

    Participants will be sedated and maintained by dexmedetomidine.

    Drug: Dexmedetomidine

  • Propofol group

    Participants will be sedated and maintained by propofol.

    Drug: Propofol

  • Remimazolam group

    Participants will be sedated and maintained by remimazolam.

    Drug: Remimazolam Injection

Interventions

  • DrugDexmedetomidine

    Participants will be sedated and maintained by dexmedetomidine during the surgery.

  • DrugPropofol

    Participants will be sedated and maintained by propofol during the surgery.

  • DrugRemimazolam Injection

    Participants will be sedated and maintained by remimazolam during the surgery.

06

What researchers measure

Primary outcomes

  1. The alterations of brain network connectivity.

    fMRI and DTI will be used to detect brain network connectivity.

    Time frame: Before sedation, 30 minutes after sedation,and 30 minutes after surgery.

Secondary outcomes

  1. Postoperative delirium.

    The incidence and severity of postoperative delirium and its association with changes of brain network connectivity.

    Time frame: Day 1-5 after surgery.

  2. Electroencephalogram changes

    Electroencephalogram will be used to record the brain activity.

    Time frame: From patients admission to operation room until 10 minutes after surgery

  3. rScO2 changes.

    Regional cerebral oxygen saturation (rScO2) will be monitored with near-infrared spectroscopy (NIRS).

    Time frame: From patients admission to operation room until 10 minutes after surgery

07

Study locations

1 of 1 sites recruiting
  • Beijing Tian Tan Hospital, Capital Medical University
    Beijing, Beijing 100070, China
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 14, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06138340
Lead sponsor
Beijing Tiantan Hospital
Responsible party
Yuming Peng (Deputy chief of Department of Anesthesiology, Beijing Tiantan Hospital) — Principal investigator
First posted
Nov 18, 2023
Start date
Aug 31, 2023
Primary completion
Nov 30, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Feb 14, 2025

Study contacts

Yuming Peng, MD,Ph.D
Contact
florapym766@163.com
8610-59976658

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion